[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DevicesIntervention group: In the second group, as in the first group, patients undergo treatment approved by the Ministry of Health. During the period of receiving Remdesivir, non-invasive ventilation is on the agenda. Before starting oxygen therapy, the clinical condition and arterial blood gas analysis of these patients will be reviewed.24 hours after non-invasive ventilation and in the next stage, 48 hours after the onset of oxygenation, clinical symptomes and ABG results of patients will be evaluated.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DevicesIntervention group: Before starting oxygen therapy, patients undergo treatment approved by the Ministry of Health. Oxygen therapy of patients is performed during the period of receiving Remdesivir. Before starting oxygen therapy, clinical examination and analysis of arterial blood gases in these patients will be on the agenda. Oxygen delivery to the patient with the high flow nasal cannula is then done (a device with Fisher & Paykel model) for 24 hours. Flow and temperature are adjusted according to the patient's satisfactory breathing. After 24 hours and in the next stage, 48 hours after the start of oxygenation, patients' clinical manifestations and ABG results will be evaluated.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 575, "treatment_name": "High flow nasal cannula", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 904, "treatment_name": "Non invasive ventilation", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}]